Improvements in health-related quality of life in people with cystic fibrosis ≥6 years of age treated with vanzacaftor/tezacaftor/deutivacaftor.
Saved in:
| Title: | Improvements in health-related quality of life in people with cystic fibrosis ≥6 years of age treated with vanzacaftor/tezacaftor/deutivacaftor. |
|---|---|
| Authors: | Wainwright CE; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia. Electronic address: Wainwright@health.qld.gov.au., Thorat T; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Conner S; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Quon BS; Centre for Heart Lung Innovation, St. Paul's Hospital, and Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Duckers J; Department of Respiratory Medicine, Cardiff and Vale University Health Board, NHS Wales, Cardiff, UK., Lou Y; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Mo C; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Xue Y; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Zhu L; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., McGarry L; Vertex Pharmaceuticals Incorporated, Boston, MA, USA. |
| Source: | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2026 Mar; Vol. 25 (2), pp. 284-289. Date of Electronic Publication: 2025 Dec 05. |
| Publication Type: | Journal Article; Clinical Trial, Phase III |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-5010 |
|---|---|
| DOI: | 10.1016/j.jcf.2025.11.014 |
